Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.
about
Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned ratRegional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions.Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Advances in non-dopaminergic treatments for Parkinson's diseaseEffects of risperidone on glutamate receptor subtypes in developing rat brainThe effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats.Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus.Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon.Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum.Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.Turning behavior induced by injections of glutamate receptor antagonists into the substantia nigra of the rat.
P2860
Q28582782-C7A1BEFB-717E-473F-89F7-2C9C640E5D2BQ33866762-7C3396C9-9E88-4225-B9E4-99A1FECED42BQ36020776-134B44F0-CC06-42FC-A028-E146E850A34EQ38218083-1D235E17-CE7A-4A08-A218-51D7BB2BE3EFQ41807633-1FA3A4C9-A4C8-4F47-AEDD-441F3966CC0FQ42446235-87686DEB-B8F2-4FD4-B7AC-1DAAC633ABD4Q43750237-A40CC8E6-A58B-45CA-84A6-D0FD3D5A12EEQ44352563-15A454FC-5B16-4825-93FD-0FEAEA9FDFE3Q46386584-EF6D6D35-F022-48AD-8F91-759450874198Q46619147-096F72BD-EA48-4131-92E0-5035B02AE272Q48092207-F71C6E3F-36E6-46A9-BB0C-E80C7C2C0DCDQ48148951-65E7E2F4-4309-4EAD-AB24-5B23A5BB6FDFQ48174974-A7A773BC-F30D-4AE7-A12B-DA00E496D3E6Q48248275-9CFE34E5-8A4D-41C7-8EF1-81E4B0664B93Q48574615-A161C70E-7203-4F33-907D-F75AA469CFADQ48906972-3398AC0E-078A-40F7-8BB8-5CE2FB0BA7FD
P2860
Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@en
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@nl
type
label
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@en
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@nl
prefLabel
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@en
Glutamate receptors in striatu ...... dial forebrain bundle lesions.
@nl
P2093
P1433
P1476
Glutamate receptors in striatu ...... edial forebrain bundle lesions
@en
P2093
P304
P356
10.1016/0006-8993(94)91642-X
P407
P577
1994-05-01T00:00:00Z